256 related articles for article (PubMed ID: 31129084)
1. The use of iPSC technology for modeling Autism Spectrum Disorders.
Russo FB; Brito A; de Freitas AM; Castanha A; de Freitas BC; Beltrão-Braga PCB
Neurobiol Dis; 2019 Oct; 130():104483. PubMed ID: 31129084
[TBL] [Abstract][Full Text] [Related]
2. Psychiatry in a Dish: Stem Cells and Brain Organoids Modeling Autism Spectrum Disorders.
Ilieva M; Fex Svenningsen Å; Thorsen M; Michel TM
Biol Psychiatry; 2018 Apr; 83(7):558-568. PubMed ID: 29295738
[TBL] [Abstract][Full Text] [Related]
3. In vitro models for ASD-patient-derived iPSCs and cerebral organoids.
Hohmann SS; Ilieva M; Michel TM
Prog Mol Biol Transl Sci; 2020; 173():355-375. PubMed ID: 32711817
[TBL] [Abstract][Full Text] [Related]
4. The Use of Induced Pluripotent Stem Cell Technology to Advance Autism Research and Treatment.
Acab A; Muotri AR
Neurotherapeutics; 2015 Jul; 12(3):534-45. PubMed ID: 25851569
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of Neurite Outgrowth and Cell Migration in Autism and Other Neurodevelopmental Disorders.
Prem S; Millonig JH; DiCicco-Bloom E
Adv Neurobiol; 2020; 25():109-153. PubMed ID: 32578146
[TBL] [Abstract][Full Text] [Related]
6. Induced pluripotent stem cells as a tool to study brain circuits in autism-related disorders.
Vitrac A; Cloëz-Tayarani I
Stem Cell Res Ther; 2018 Aug; 9(1):226. PubMed ID: 30139379
[TBL] [Abstract][Full Text] [Related]
7. Modeling Autism Spectrum Disorders with Induced Pluripotent Stem Cell-Derived Brain Organoids.
Santos JLS; Araújo CA; Rocha CAG; Costa-Ferro ZSM; Souza BSF
Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830629
[TBL] [Abstract][Full Text] [Related]
8. Autism spectrum disorders and disease modeling using stem cells.
Brito A; Russo FB; Muotri AR; Beltrão-Braga PCB
Cell Tissue Res; 2018 Jan; 371(1):153-160. PubMed ID: 28918504
[TBL] [Abstract][Full Text] [Related]
9. Human stem cell-based models for studying autism spectrum disorder-related neuronal dysfunction.
Cheffer A; Flitsch LJ; Krutenko T; Röderer P; Sokhranyaeva L; Iefremova V; Hajo M; Peitz M; Schwarz MK; Brüstle O
Mol Autism; 2020 Dec; 11(1):99. PubMed ID: 33308283
[TBL] [Abstract][Full Text] [Related]
10. Idiopathic Autism: Cellular and Molecular Phenotypes in Pluripotent Stem Cell-Derived Neurons.
Liu X; Campanac E; Cheung HH; Ziats MN; Canterel-Thouennon L; Raygada M; Baxendale V; Pang AL; Yang L; Swedo S; Thurm A; Lee TL; Fung KP; Chan WY; Hoffman DA; Rennert OM
Mol Neurobiol; 2017 Aug; 54(6):4507-4523. PubMed ID: 27356918
[TBL] [Abstract][Full Text] [Related]
11. Modeling the autistic cell: iPSCs recapitulate developmental principles of syndromic and nonsyndromic ASD.
Ben-Reuven L; Reiner O
Dev Growth Differ; 2016 Jun; 58(5):481-91. PubMed ID: 27111774
[TBL] [Abstract][Full Text] [Related]
12. Generation of an induced pluripotent stem cell line from a patient with autism spectrum disorder and SCN2A haploinsufficiency.
Sampaio GLA; Martins GLS; Paredes BD; Nonaka CKV; da Silva KN; Rossi EA; Dos Santos RR; Soares MBP; Souza BSF
Stem Cell Res; 2019 Aug; 39():101488. PubMed ID: 31272037
[TBL] [Abstract][Full Text] [Related]
13. Human Inducible Pluripotent Stem Cells and Autism Spectrum Disorder: Emerging Technologies.
Nestor MW; Phillips AW; Artimovich E; Nestor JE; Hussman JP; Blatt GJ
Autism Res; 2016 May; 9(5):513-35. PubMed ID: 26426199
[TBL] [Abstract][Full Text] [Related]
14. Disease Modeling of Neuropsychiatric Brain Disorders Using Human Stem Cell-Based Neural Models.
Kaindl J; Winner B
Curr Top Behav Neurosci; 2019; 42():159-183. PubMed ID: 31407242
[TBL] [Abstract][Full Text] [Related]
15. Development of a 3-D Organoid System Using Human Induced Pluripotent Stem Cells to Model Idiopathic Autism.
Lunden JW; Durens M; Nestor J; Niescier RF; Herold K; Brandenburg C; Lin YC; Blatt GJ; Nestor MW
Adv Neurobiol; 2020; 25():259-297. PubMed ID: 32578151
[TBL] [Abstract][Full Text] [Related]
16. The Autism Spectrum Disorders Stem Cell Resource at Children's Hospital of Orange County: Implications for Disease Modeling and Drug Discovery.
Brick DJ; Nethercott HE; Montesano S; Banuelos MG; Stover AE; Schutte SS; O'Dowd DK; Hagerman RJ; Ono M; Hessl DR; Tassone F; Schwartz PH
Stem Cells Transl Med; 2014 Nov; 3(11):1275-86. PubMed ID: 25273538
[TBL] [Abstract][Full Text] [Related]
17. Using iPSC-Based Models to Understand the Signaling and Cellular Phenotypes in Idiopathic Autism and 16p11.2 Derived Neurons.
Turkalj L; Mehta M; Matteson P; Prem S; Williams M; Connacher RJ; DiCicco-Bloom E; Millonig JH
Adv Neurobiol; 2020; 25():79-107. PubMed ID: 32578145
[TBL] [Abstract][Full Text] [Related]
18. Personalized genome sequencing coupled with iPSC technology identifies GTDC1 as a gene involved in neurodevelopmental disorders.
Aksoy I; Utami KH; Winata CL; Hillmer AM; Rouam SL; Briault S; Davila S; Stanton LW; Cacheux V
Hum Mol Genet; 2017 Jan; 26(2):367-382. PubMed ID: 28365779
[TBL] [Abstract][Full Text] [Related]
19. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
20. Patient-Derived Stem Cells, Another
Maussion G; Rocha C; Bernard G; Beitel LK; Durcan TM
Front Pediatr; 2019; 7():225. PubMed ID: 31245336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
